{"id":"https://openalex.org/W2118710260","doi":"https://doi.org/10.1210/jc.2010-2318","title":"GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide","display_name":"GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-05","ids":{"openalex":"https://openalex.org/W2118710260","doi":"https://doi.org/10.1210/jc.2010-2318","mag":"2118710260","pmid":"https://pubmed.ncbi.nlm.nih.gov/21209033"},"language":"en","primary_location":{"id":"doi:10.1210/jc.2010-2318","doi":"https://doi.org/10.1210/jc.2010-2318","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2010-2318","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2118710260"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039528393","display_name":"L\u00e1szl\u00f3 D\u00e1vid Heged\u0171s","orcid":"https://orcid.org/0000-0002-9691-7619","observed_orcids":["https://orcid.org/0000-0002-9691-7619"]},"institutions":[{"id":"https://openalex.org/I2801498763","display_name":"Odense University Hospital","ror":"https://ror.org/00ey0ed83","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801498763"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Laszlo Heged\u00fcs","raw_affiliation_strings":["Department of Endocrinology (L.H.), Odense University Hospital, 5000 Odense, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology (L.H.), Odense University Hospital, 5000 Odense, Denmark;","institution_ids":["https://openalex.org/I2801498763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104132238","display_name":"Alan Charles Moses","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan C. Moses","raw_affiliation_strings":["Novo Nordisk Inc. (A.C.M.), Princeton, New Jersey 08540;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk Inc. (A.C.M.), Princeton, New Jersey 08540;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Milan Zdravkovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Milan Zdravkovic","raw_affiliation_strings":["Novo Nordisk A/S (M.Z., T.L.T.), 2880 Bagsv\u00e6rd, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S (M.Z., T.L.T.), 2880 Bagsv\u00e6rd, Denmark;","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110001248","display_name":"Tu D. L. Thi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Tu Le Thi","raw_affiliation_strings":["Novo Nordisk A/S (M.Z., T.L.T.), 2880 Bagsv\u00e6rd, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S (M.Z., T.L.T.), 2880 Bagsv\u00e6rd, Denmark;","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028469549","display_name":"Gilbert H. Daniels","orcid":"https://orcid.org/0000-0003-0431-2792","observed_orcids":["https://orcid.org/0000-0003-0431-2792"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gilbert H. Daniels","raw_affiliation_strings":["Thyroid Unit (G.H.D.), Endocrine Tumor Center and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thyroid Unit (G.H.D.), Endocrine Tumor Center and Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5039528393"],"corresponding_institution_ids":["https://openalex.org/I2801498763"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":18.0982,"has_fulltext":true,"cited_by_count":202,"citation_normalized_percentile":{"value":0.99640821,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"96","issue":"3","first_page":"853","last_page":"860"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8446999788284302,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8446999788284302,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.0272000003606081,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.02630000002682209,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcitonin","display_name":"calcitonin","score":0.8090000152587891},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9190000295639038},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9810000061988831},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9229999780654907},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/medullary-thyroid-carcinoma","display_name":"medullary thyroid carcinoma","score":0.8920000195503235},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.48399999737739563},{"id":"https://openalex.org/keywords/rodent-to-human-extrapolation","display_name":"rodent-to-human extrapolation","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C2779627488","wikidata":"https://www.wikidata.org/wiki/Q315860","display_name":"Calcitonin","level":2,"score":0.776009202003479},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6800528764724731},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6547582745552063},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5835169553756714},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5815038681030273},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.4559316337108612},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.34034281969070435},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1674497425556183},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002116","descriptor_name":"Calcitonin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D048909","descriptor_name":"Diabetes Complications","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1210/jc.2010-2318","doi":"https://doi.org/10.1210/jc.2010-2318","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2010-2318","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:21209033","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21209033","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/ae22d1a5-b60c-4b78-83eb-3b6409bb18a4","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/ae22d1a5-b60c-4b78-83eb-3b6409bb18a4","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heged\u00fcs, L, Moses, A C, Zdravkovic, M, Le Thi, T & Daniels, G H 2011, 'GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide', The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 3, pp. 853-860. https://doi.org/10.1210/jc.2010-2318","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320322441","display_name":"Odense Universitetshospital","ror":"https://ror.org/00ey0ed83"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1981934184","https://openalex.org/W1989888312","https://openalex.org/W2004409542","https://openalex.org/W2011755276","https://openalex.org/W2012425163","https://openalex.org/W2016279245","https://openalex.org/W2032909498","https://openalex.org/W2062748012","https://openalex.org/W2070100313","https://openalex.org/W2071835038","https://openalex.org/W2084399626","https://openalex.org/W2098459806","https://openalex.org/W2098905490","https://openalex.org/W2113367996","https://openalex.org/W2120141122","https://openalex.org/W2137352234","https://openalex.org/W2138290933","https://openalex.org/W2140004965","https://openalex.org/W2152835319","https://openalex.org/W2160001758","https://openalex.org/W2170606300","https://openalex.org/W2509949587","https://openalex.org/W3023775406","https://openalex.org/W4230171946","https://openalex.org/W4247313807"],"related_works":["https://openalex.org/W2004409542","https://openalex.org/W1924310175","https://openalex.org/W2166969890","https://openalex.org/W2778933123","https://openalex.org/W2086006571","https://openalex.org/W2124733490","https://openalex.org/W2158351892","https://openalex.org/W4231047657","https://openalex.org/W2950862625","https://openalex.org/W4410208160"],"abstract_inverted_index":{"BACKGROUND:":[0],"Serum":[1],"calcitonin":[2],"(CT)":[3],"is":[4],"a":[5,51,122,188,257],"well-accepted":[6],"marker":[7],"of":[8,54,65,77,124,145,181,192,224,251,259],"C-cell":[9,34],"proliferation,":[10],"particularly":[11],"in":[12,23,44,94,121,126,148,198,232,240],"medullary":[13,47,55],"thyroid":[14,48,56],"carcinoma.":[15],"Chronic":[16],"glucagon-like":[17],"peptide-1":[18],"(GLP-1)":[19],"receptor":[20,67,91,226,253],"agonist":[21,92,254],"administration":[22],"rodents":[24,241],"has":[25],"been":[26],"associated":[27],"with":[28,96],"increased":[29,186],"serum":[30,71,83,107,229],"CT":[31,43,72,84,108,138,184,230],"levels":[32,185,231],"and":[33,58,152,178,209,234],"tumor":[35],"formation.":[36],"There":[37,201],"are":[38,256],"no":[39,59,116,166,203,210],"longitudinal":[40],"studies":[41,61],"measuring":[42],"humans":[45,233],"without":[46],"carcinoma":[49,57],"or":[50,101,132,206],"family":[52],"history":[53],"published":[60],"on":[62,69,228],"the":[63,78,89,142,156,248],"effect":[64,223],"GLP-1":[66,90,225,252],"agonists":[68],"human":[70],"concentrations.":[73],"AIM:":[74],"The":[75],"aim":[76],"study":[79],"was":[80,202],"to":[81,88,245],"determine":[82],"response":[85],"over":[86,127],"time":[87],"liraglutide":[93,131],"subjects":[95,129,182],"type":[97],"2":[98,119,159],"diabetes":[99],"mellitus":[100],"nondiabetic":[102],"obese":[103],"subjects.":[104],"METHODS:":[105],"Unstimulated":[106],"concentrations":[109,139],"were":[110,140,165,195],"measured":[111],"at":[112,141],"3-month":[113],"intervals":[114],"for":[115,176],"more":[117],"than":[118,168],"yr":[120],"series":[123],"trials":[125],"5000":[128],"receiving":[130],"control":[133],"therapy.":[134],"RESULTS:":[135],"Basal":[136],"mean":[137,163],"low":[143,154,197],"end":[144],"normal":[146,174],"range":[147],"all":[149,199],"treatment":[150,214,255],"groups":[151],"remained":[153],"throughout":[155],"trials.":[157],"At":[158],"yr,":[160],"estimated":[161],"geometric":[162],"values":[164],"greater":[167],"1.0":[169],"ng/liter,":[170],"well":[171],"below":[172],"upper":[173],"ranges":[175],"males":[177],"females.":[179],"Proportions":[180],"whose":[183],"above":[187],"clinically":[189],"relevant":[190],"cutoff":[191],"20":[193],"ng/liter":[194],"very":[196],"groups.":[200,215],"consistent":[204,211],"dose":[205],"time-dependent":[207],"relationship":[208],"difference":[212],"between":[213],"CONCLUSIONS:":[216],"These":[217],"data":[218],"do":[219],"not":[220,243],"support":[221],"an":[222],"activation":[227],"suggest":[235],"that":[236],"findings":[237],"previously":[238],"reported":[239],"may":[242],"apply":[244],"humans.":[246],"However,":[247],"long-term":[249],"consequences":[250],"subject":[258],"further":[260],"studies.":[261]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2118710260","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":26},{"year":2014,"cited_by_count":19},{"year":2013,"cited_by_count":28},{"year":2012,"cited_by_count":29}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
